• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (4)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Radiation Therapy  • Review  • Prognosis/ Outcomes  • Alert me on articles by topic  Social Bookmarking   What's this?

Nancy Han, MD; Susan Galandiuk, MD

Arch Surg. 2006;141:1246-1252.

Objective  To review the application, outcome, and recent developments of neoadjuvant chemoradiation therapy with respect to rectal cancer.

Data Sources and Study Selection  Articles written in English after 1980 selected from MEDLINE and PubMed from the National Library of Medicine. Case reports were excluded. There were no other criteria for exclusion of published information pertaining to this topic.

Data Extraction and Synthesis  Articles were obtained and organized from MEDLINE and PubMed as well as the reference lists of pertinent literature.

Conclusions  Published reports have demonstrated that neoadjuvant chemoradiation improves survival and decreases local recurrence in patients with stage II and III rectal cancers. It is anticipated that advances and technical developments in both chemotherapy and radiation therapy will lead to improved oncologic results with decreased toxic side effects.

Author Affiliations: Section of Colon and Rectal Surgery, Department of Surgery, University of Louisville School of Medicine, Louisville, Ky.

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Induction Chemoradiation for Rectal Cancer—Invited Critique
Susan L. Gearhart
Arch Surg. 2006;141(12):1253.
EXTRACT | FULL TEXT